Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction
Fig 1
Icariin promotes the in vivo survival of ADSCs and the ADSCs induced recovery of erectile function of DMED rats.
A) The in vivo survival of ADSCs before and after administrating icariin was assessed by Dil staining. B) and C) ICP and MAP measurements were employed in the assessment of erectile function of DMED rats. The rats were injected with saline or ADSCs followed by feeding up with saline or icariin for 4 weeks. The ICP value and the ratio of total ICP to MAP were calculated, n = 7. * p<0.01 compared with the control saline treated group, # p<0.01 compared with icariin treated group. $ p<0.01 compared with the ADSCs treated group. Scale bar: 50 μm.